News

Collaborative effort builds upon 2009 Good Clinical Practices Initiative

Many Israeli pharmaceutical executives recently learned that the 505(b)(2) development process is an important tool that can significantly reduce costs and shorten the timeline for approval of new drugs, adding substantially to ROI.

The European Medicines Agency has now reviewed all comments received on its draft policy on publication and access to clinical trial data.

It will then be standard practice to publish the agendas at the start of each meeting and the minutes after their adoption the following month.

The Association for the Accreditation of Human Research Protection Programs today announced that it has awarded accreditation to five more organizations

SPIRITT Selects iMedNet EDC for its eClinical Flexibility and Ease of Use

Siemens Healthcare Diagnostics Inc. announces that it has entered into a master collaboration agreement with Pfizer Inc.

Siemens Healthcare Diagnostics Inc. has entered into a master collaboration agreement with Pfizer

Quality metrics are hard to define and measure, but are crucially important.

Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital.

The final version of the EMA Reflection Paper on Risk Based Quality Management in Clinical Trials is now available.

Three different drugs developed in Finland have received a marketing authorization during the past year, and a positive decision is expected on the application of a fourth marketing authorization.

When serious things go wrong with a trial, such as an adverse event or an incident report is filed, it is easier for project managers to identify a problem that needs to be addressed in a trial.

Three different drugs developed in Finland have received a marketing authorization during the past year, and a positive decision is expected on the application of a fourth marketing authorization.

Cloud-based platform provides real-time data insights for clinical trials

With the average clinical trial using of 5-7 different clinical systems, one of the critical business challenges the industry faces today is turning these siloes of data into operational intelligence

Venn Life Sciences, a CRO providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the recent acquisition of two European CROs.

Venn Life Sciences, a growing Clinical Research Organization providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the recent acquisition of two European Clinical Research Organizations.

Innovative uses of social media and other new information technology has become increasingly important in improving clinical research operations and sponsor communications with sites, investigators and vendors.

DAC Patient Recruitment Services has rolled out DACTracks, a proprietary clinical trial metrics technology.

As a clinical trial sponsor, being able to measure research programs with pinpoint accuracy is a valuable proposition.

DaVita Clinical Research launched its "Inspired to Give" campaign, which shares stories from the people behind clinical research.

Government incentives and cost of trials not critical factors

Veeva Systems announces new CRO partnership program to support growing trends in eTMF outsourcing and cloud adoption

Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program.

DaVita Clinical Research launched its "Inspired to Give" campaign

Against the backdrop of recent statistics showing that applications to run clinical trials in Europe fell 25% between 2007-2011

CLINICAL SERVICES PACKAGER TO EXPAND NORTH AMERICAN OPERATIONS